![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Smilax Laboratories Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.
One of their significant offerings is Omeprazole, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-052 - Rev 00
This Chemical Type CEP, issued on September 28, 2015, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 942 associated with this CEP further emphasizes